Results 21 to 30 of about 5,690,964 (274)
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
The Journal of the National Comprehensive Cancer Network, 2021 The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC.
D. Ettinger +37 more
semanticscholar +1 more source
Chinese Journal of Lung Cancer, 2023 Erratum: Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression Guo JJ, Mu D, Yu WW, et al. Zhongguo Fei Ai Za Zhi, 2023, 26(2): 105-112.
Editorial Office of Chinese Journal of Lung Cancer
doaj +1 more source
Pembrolizumab plus Chemotherapy for Squamous Non–Small‐Cell Lung Cancer
New England Journal of Medicine, 2018 Background Standard first‐line therapy for metastatic, squamous non–small‐cell lung cancer (NSCLC) is platinum‐based chemotherapy or pembrolizumab (for patients with programmed death ligand 1 [PD‐L1] expression on ≥50% of tumor cells).
L. Paz-Ares +21 more
semanticscholar +1 more source
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Science, 2004 Receptor tyrosine kinase genes were sequenced in non–small cell lung cancer (NSCLC) and matched normal tissue. Somatic mutations of the epidermal growth factor receptor gene EGFR were found in 15of 58 unselected tumors from Japan and 1 of 61 from the ...
J. Paez +16 more
semanticscholar +1 more source
Ca, 2023 Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer ...
R. Siegel +3 more
semanticscholar +1 more source
Thoracic Cancer, 2021 Background Lung cancer, mainly non‐small cell lung cancer (NSCLC), is one of the leading causes of death worldwide. Currently, chemotherapy is still the most significant treatment strategy for NSCLC.
Jinghao Liu +11 more
doaj +1 more source
Sensor technologies in cancer research for new directions in diagnosis and treatment: and exploratory analysis [PDF]
arXiv, 2022 The goal of this study is an exploratory analysis concerning main sensor technologies applied in cancer research to detect new directions in diagnosis and treatments. The study focused on types of cancer having a high incidence and mortality worldwide: breast, lung, colorectal and prostate.
arxiv
Improving diagnosis and prognosis of lung cancer using vision transformers: A scoping review [PDF]
arXiv, 2023 Vision transformer-based methods are advancing the field of medical artificial intelligence and cancer imaging, including lung cancer applications. Recently, many researchers have developed vision transformer-based AI methods for lung cancer diagnosis and prognosis.
arxiv
Primary chondroma of posterior mediastinum with Horner’s syndrome: a case report
World Journal of Surgical Oncology, 2018 Background Chondroma is a slowly growing, benign cartilaginous tumor which predominantly occurs in long bones of the hands and feet. Primary mediastinal chondroma is rare, especially with Horner’s syndrome.
Xiaoqian Xu +5 more
doaj +1 more source
BMC Pulmonary Medicine, 2021 Background The echinoderm microtubule-associated protein-like-4 anaplastic lymphoma kinase (EML4-ALK) fusion gene was identified in a subset of non-small cell lung cancer (NSCLC) patients. They responded positively to ALK inhibitors.
Ying Li +6 more
doaj +1 more source